Tetsuya Takimoto Selected Research

Wilms Tumor (Wilm's Tumor)

4/2019	Blastemal predominant type Wilms tumor in Japan: Japan Children's Cancer Group.
10/2015	Management of pediatric renal tumor: Past and future trials of the Japan Wilms Tumor Study Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tetsuya Takimoto Research Topics

Disease

8	Neoplasms (Cancer) 12/2021 - 09/2014
4	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2015
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2018 - 06/2014
3	Lymphoma (Lymphomas) 03/2016 - 06/2014
2	Neuroblastoma 05/2022 - 12/2020
2	Hepatoblastoma 01/2022 - 12/2017
2	Wilms Tumor (Wilm's Tumor) 04/2019 - 10/2015
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 02/2018 - 01/2014
2	Leukemia 03/2016 - 01/2007
1	Fatigue 01/2022
1	Fever (Fevers) 01/2022
1	Infections 01/2022
1	Anorexia 01/2022
1	Mucositis 01/2022
1	Nausea 01/2022
1	Macular Degeneration (Age-Related Maculopathy) 01/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 12/2021
1	Bone Marrow Failure Disorders 11/2020
1	Sudden Infant Death (SID) 12/2019
1	Neutropenia 11/2019
1	Chronic Granulomatous Disease 01/2019
1	Hypertrophy 01/2018
1	Retinal Diseases 11/2016
1	Central Nervous System Diseases (CNS Diseases) 03/2016
1	Rhabdoid Tumor (Rhabdoid Tumors) 10/2015
1	Metabolic Diseases (Metabolic Disease) 06/2014
1	Thrombocytopenia (Thrombopenia) 06/2014
1	Body Weight (Weight, Body) 12/2011
1	Hemangioma (Angioma) 12/2011
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2011
1	Inflammation (Inflammations) 06/2008

Drug/Important Bio-Agent (IBA)

2	Biological ProductsIBA 12/2020 - 10/2015
2	Methotrexate (Mexate)FDA LinkGeneric 01/2015 - 01/2014
2	SteroidsIBA 06/2014 - 12/2011
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022
1	EnzymesIBA 01/2022
1	Ferritins (Ferritin)IBA 12/2021
1	DNA (Deoxyribonucleic Acid)IBA 12/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2021
1	leucyl-lysineIBA 12/2019
1	Busulfan (Busulfex)FDA Link 01/2019
1	Anaplastic Lymphoma KinaseIBA 02/2018
1	CollagenIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Retinaldehyde (Retinal)IBA 11/2016
1	Biomarkers (Surrogate Marker)IBA 10/2015
1	petasinIBA 06/2014
1	AMP-Activated Protein KinasesIBA 06/2014
1	lysine(6)- glutaryl- 2- (hydroxymethyl)anthraquinone LHRH (T 98)IBA 06/2014
1	LipopolysaccharidesIBA 12/2011
1	nelarabine (506U78)FDA Link 06/2011
1	CytokinesIBA 06/2008
1	LigandsIBA 06/2008

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2022 - 01/2015
5	Therapeutics 08/2018 - 01/2007
3	Radiotherapy 10/2018 - 09/2014
2	Hematopoietic Stem Cell Transplantation 05/2022 - 11/2020
2	Induction Chemotherapy 10/2018 - 12/2017
1	Homologous Transplantation 01/2019
1	Metastasectomy 12/2017
1	Liver Transplantation 06/2014
1	Spinal Injections 01/2014